Financial News
Latest News about BLFS
Recent news which mentions BLFS
BioLife Solutions's Return On Capital Employed Insights
December 15, 2022
Tickers
BLFS
From Benzinga
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
December 13, 2022
From MarketWatch
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 10, 2022
From Benzinga
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
November 10, 2022
From Benzinga
From Benzinga
From InvestorPlace
60 Biggest Movers From Yesterday
April 26, 2022
From Benzinga
34 Stocks Moving In Monday's Mid-Day Session
April 25, 2022
From Benzinga
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
From Benzinga
Wall Street analysts’ favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors
December 31, 2021
From MarketWatch
BioLife Solutions Inc (BLFS) Q3 2021 Earnings Call Transcript
November 11, 2021
Tickers
BLFS
From Motley Fool
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
From Benzinga
Earnings Scheduled For November 11, 2021
November 11, 2021
From Benzinga
From Motley Fool
Looking Into BioLife Solutions's Return On Capital Employed
September 29, 2021
Tickers
BLFS
From Benzinga
Notable Biolife Solutions Insider Trades $971 Thousand In Company Stock
September 23, 2021
Tickers
BLFS
From Benzinga
Why Shares in BioLife Solutions Jumped 24.4% in August
September 07, 2021
Tickers
BLFS
From Motley Fool
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
